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Abstract
Background: The vast computational resources that became available during the past decade enabled the development
and simulation of increasingly complex mathematical models of cancer growth. These models typically involve many free
parameters whose determination is a substantial obstacle to model development. Direct measurement of biochemical
parameters in vivo is often difficult and sometimes impracticable, while fitting them under data-poor conditions may result
in biologically implausible values.
Results: We discuss different methodological approaches to estimate parameters in complex biological models. We make
use of the high computational power of the Blue Gene technology to perform an extensive study of the parameter space in
a model of avascular tumor growth. We explicitly show that the landscape of the cost function used to optimize the model
to the data has a very rugged surface in parameter space. This cost function has many local minima with unrealistic
solutions, including the global minimum corresponding to the best fit.
Conclusions: The case studied in this paper shows one example in which model parameters that optimally fit the data are
not necessarily the best ones from a biological point of view. To avoid force-fitting a model to a dataset, we propose that
the best model parameters should be found by choosing, among suboptimal parameters, those that match criteria other
than the ones used to fit the model. We also conclude that the model, data and optimization approach form a new complex
system and point to the need of a theory that addresses this problem more generally.
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Introduction
A necessary step in making predictions from mathematical
models of biological processes is the estimation of the parameters
needed to simulate the model. This is a well studied problem in
systems biology, usually addressed utilizing a large variety of
approaches [1–5].
Fitting parameters of mechanistic models to experimental data
is usually a daunting task [6]. There are several difficulties
associated with parameter fitting. One such difficulty stems for the
fact that models may display sloppy parameter sensitivities [7,8],
whereby some parameters can compensate other parameters,
resulting in some arbitrariness in the specification of their values.
Another generic difficulty is that different values of the model
parameters may be similarly consistent with the data (the problem
of identifiability). Yet a third difficulty is that finding the optimal
values of the model parameters may require the exploration of a
huge space. In this paper we highlight a fourth difficulty usually
not discussed when fitting parameters to data. Given a model that
is only an approximate representation of a system under study, and
data extracted from this system, the model parameters that best
represent the mechanistic details of the system may not be found
by minimizing a cost function. In other words, the parameters at
the global minimum of the cost function may not yield the most
meaningful parameters from a physiological point of view. In
effect, when minimizing a cost function the optimization process
can force the search to go to a corner of the parameter space
which, while fitting the data exquisitely, yields physiologically
meaningless parameters. In view of these difficulties, the question
of how to approach the generic problem of searching the
parameter space of models that are only approximate represen-
tations of complex systems remains a challenging one.
The utilization of mathematical models to describe and predict
morphological and physiological aspects of tumor growth [9] has
the potential to increase our understanding of tumor development,
and holds the promise to suggest new ways to improve the efficacy
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complex mathematical models of cancerous growth have been
developed, in particular on solid tumors, in which growth
primarily comes from cellular proliferation [10,11]. The growth
of micro-tumors in the avascular stage can be studied using
multicellular spheroids as a biological model [12–14]. The
multicellular spheroid model [15] is at present considered an
excellent in vitro model to study complex aspects of tumor
physiology, especially those related to therapeutic strategies that
cannot be adequately treated by other simpler models [16,17].
This kind of model represents an intermediate level of complexity
between in vitro monolayer cell cultures and in vivo solid tumors.
Ward and King [18] proposed a mathematical representation of
the processes that describe the growth or remission of an avascular
micro-tumor in terms of the nutrient concentration present in the
medium, based on a system of nonlinear partial differential
equations. The model assumes the existence of a continuum of
cells in two possible states: alive or dead. According to the
concentration of a generic nutrient, the living cell may reproduce
or die, following a saturation kinetics. The division or death of cells
implies the expansion or contraction of the tumor volume. The
growth of an avascular tumor can be described by the temporal
dependence of the radius of its spheroidal volume. This radius is
easily accessible by experimentation, and can in principle be used
to constrain the parameters of avascular tumor growth models.
We are interested in fitting the parameters of an avascular tumor
growth model [18] using time course data. This is a good system to
explore the above-mentioned difficulties, associated with parame-
terizing a model. On the one hand this model has six parameters
which is a large, yet manageable number of parameters. On the
other hand, the influence of these parameters on the final shape of
the growth curve is far from obvious, and therefore there is no
simple way to estimate the parameters from exploration of the
growth curve. To fit the parameters in this model we did a
systematic exploration of the cost function defined as the sum of the
squares of the differences between model prediction and time
course data, summed over the observed time points. To minimize
this cost function we implemented and tested four different
algorithms: (1) Levenberg-Marquardt [19,20]; (2) Fletcher-Davi-
don-Powell [21]; (3) Downhill Simplex [22]; (4) Parallel Tempering
[23]. Each of these methods belongs to different families of
optimization techniques, described below. We use the massive
parallel architecture of a Blue Gene supercomputer to sample the
parameter space and characterize the rugged nature of the solution
landscape. We found the surprising result that the global minimum
of the cost function is not biologically meaningful. This conclusion
indicates that the global minimum of the cost function might not be
the place to look for the parameters of our model.
In subsequent sections, we will present and discuss strategies to
find the parameters of this model, characterize the cost function
landscape, and study the parameters they yield in terms of pre-
existing biological knowledge.
Methods
Model of avascular tumor growth
A detailed description of the mathematical aspects of the
avascular tumor growth model to be considered in this paper can
be found in the original reference [18], while the numerical
implementation of the solution has been described in [24]. In this
section, we summarize the basic tenets of the model with the aim of
introducing the parameters whose values we want to fit from
experimental data. As the experimental model is a spheroid, we can
assume a spherically symmetric system whose variables depend on
the spatial coordinates only through the radius r, i.e., the distance
form any point in the spheroid to a fixed center. Three variables
determine the model: i) the density of living cells, n(r,t); ii) the local
growth velocity, v(r,t); and iii) the nutrient concentration, c(r,t).
After non-dimensionalization and some reordering of the terms
[18], the equations for the density of living cells is:
Ln
Lt
zv
Ln
Lr
~ ½km(c){kd(c) (1{n){dkd(c)n fg n,
where km(c) and kd(c) are the rate of mitosis and death
respectively, and d is the fraction of the original cell volume that
a cell occupies after it dies, i.e., d~VD=VL with VL and VD
denoting the volume of a living and dead cell respectively. The
dependencies of km and kd on the concentration are given by
saturating functions assumed to have the form
km(c)~
c
czcc
, kd(c)~1{s
c
czcd
:
The parameter cc represents the crossover concentration above
which the rate of mitosis reaches its normalized saturation value of
1. In like manner, the critical concentration cd denotes the
crossover concentration of nutrient below which the normalized
death rate saturates to 1 and above which the normalized death
rate saturates to 1{s; here, s denotes the basal cell death rate
parameter, which is independent of nutrient conditions.
The equation for the normalized local velocity is [18]
1
r2
L(r2v)
Lr
~½km(c){(1{d)kd(c) n:
Finally, we will use the equation for the nutrient concentration
inside the spheroid. This equation results from a quasi-steady
approximation of the reaction diffusion equation ruling the
nutrient concentration:
1
r2
L
Lr
r2 Lc
Lr
  
~bkm(c)n,
where b represents the amount of nutrient consumed on cell
mitosis. It is assumed that the nutrient consumption by non-
mitotic processes is much smaller than that the nutrients consumed
during mitosis.
The initial conditions
rbd(0)~1, n(r,0)~1, c(r,0)~cbd,
specify that the radius rbd(t) at the boundary of the tumor at time
t~0 is our unit of lengths and that the initial density of cells n(r,0)
is one, that is we start with a unique cell submerged in a medium
with nutrient concentration given by cbd, the latter being also the
nutrient concentration at the tumor boundary.
The boundary conditions are:
drbd
dt
~v(rbd(t),t), c(rbd(t),t)~cbd,
v(0,t)~0,
Lc(0,t)
Lr
~0:
The first boundary condition in the first line implies that the
boundary of the spheroid moves with the local velocity at the
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spheroid is immersed in a medium with nutrient concentration
cbd. The third and fourth boundary conditions (second line) are
respectively that the center of the tumor is not moving (i.e., our
center of coordinates is at the center of the tumor), and that the
radial gradient of concentration at the center has to be zero by the
spherical symmetry.
In summary, this model has 6 free parameters, represented by a
6-dimensional array h~(d,s,b,cc,cd,cbd). The original model as
formulated in [18] had four additional parameters, which we are
setting to the values suggested in [18]. By their normalization, our
six parameters are contained in the interval ½0,1 . Different
combinations of parameters lead to one of three possible
evolutions: linearly increasing, saturating, and decreasing (Figure
S1 in File S1).
Experimental Data
Multicellular spheroid techniques have been widely used and
studied since the 1980’s [25–28]. One of the most important
measures obtained from these spheroids is the growth curve, i.e.,
the radius or volume of the spheroids as a function of time. With
the experimental technology currently available, this curve can be
measured very precisely. In [13,14] the authors measured the
growth curve of multicellular tumor spheroids used as paradigms
of prevascular and microregional tumor growth and compared the
experimental growth curves to many different empirical models of
multicellular spheroid growth. The authors concluded that the
standard Gompertz curve [29], defined as rbd(t)~aexp½bexp(ct) 
could not be distinguished from the actual growth curves within
the margin of error of the experimental data. Taking into account
these observations we used a noisy Gompertz curve to constrain
the parameters of our tumor growth model. We generated
synthetic growth data from a Gompertz model that was previously
shown [13,14] to follow very closely experimental volume growth
data with values of a~7:6, b~{12 and c~{0:121. We also
added 5% of noise to the volume growth curve, a level of noise
similar to what is observed in real experiments. Figure 1 shows the
volumetric growth curve generated using the Gompertz model
with 5% of noise (left panel), as well as the corresponding non-
dimensionalized radius growth curve (right panel). The latter curve
will be used in the remaining of this paper to constrain the
parameters of a tumor growth model.
Parameter Estimation
The parameters included in the tumor growth model are
represented by the 6-dimensional array h. In order to obtain
numerical values for our model parameters, we will attempt to
minimize the differences between our tumor growth model and
the data by finding the minima of the quadratic cost function [30]:
x2(h)~
X N
k~0
(yk(h){datak)
2,
where yk(h) is the model’s prediction for observation k which
depends on the parameters h, and datak represents the
experimentally measured data values (in our case, synthetic data)
at observation k. In our particular application, synthetic
experimental observations are taken at times tk, and the value
datak corresponds to the radius of the spheroid at time tk. The
model prediction for the spheroid radius at time tk is denoted by
yk(h), and the sum is over all the time points tk. For future
reference, the residuals vector f is defined as fk~yk(h){datak.
The methods used for the minimization of the cost function are
Levenberg-Marquardt [19], Parallel tempering [23], MIGRAD
[31] and downhill simplex [22] (see supplemental section 2 for
method details).
Because of the complexity of our partial-differential-equation
based model, the simulation of each spheroid growth may take
several minutes in a single Blue Gene [32,33] node, the exact time
depending on the parameter values. To have a dense sampling of
the parameter space, independent runs were implemented and
executed in a massively parallel environment. Communication
between nodes was implemented using MPI [34]. The paralleliza-
tion consisted of running the different methods from many starting
points simultaneously and parallelizing the independent model
evaluations, i.e. Jacobian calculation in LM or MIGRAD and
different temperature simulations in PT. To sample the parameter
space with the goal of identifying the minima of the cost function,
hundreds of thousands of runs were executed. These runs took
several months even leveraging the thousands of compute nodes
available in Blue Gene. The availability of these resources resulted
in a relatively dense evaluation of the parameter space, and the
identification of what seems to be the global minimum of the cost
function.
Results
As explained in the previous sections, the model has 6 free
parameters h~(d,s,b,cc,cd,cbd), each bounded in the ½0,1 
interval. Sometimes we will refer to the parameters as Parameter
1, Parameter 2, etc., with the number indicating the order in the
parameter array. We will first show a comparative evaluation of
the advantages and disadvantages of the different optimization
approaches. For this we will use each method to minimize the cost
function x2(h) defined in the previous section, where: (a) datak
corresponds to the non-dimensional tumor radius at time tk, given
by non-dimensional synthetic data (right panel of Figure 1) and (b)
yk(h) is the tumor radius at time tk, rbd(tk) that results from
running the avascular tumor growth model with parameters h.
Figure 1. Data generated using a Gompertz model that fitted
previously reported experimental data. Gompertzian fit to the
measured volumetric data with a 5% of noise added. The in-box axis
corresponds to the same data, where the non-dimensionalized radius as
a function of non-dimensionalized time is illustrated, used as the data in
the remaining of this paper.
doi:10.1371/journal.pone.0013283.g001
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radius of the tumor over 100 time points tk as shown in Figure 1.
Our objective is to determine which parameter sets h minimize
x2(h). A six-dimensional grid of two inner points for each
parameter was generated for the initial parameter values from
where to start the optimizations. For each of the four optimization
methods to be explored, these 64 mesh points were executed in
parallel. For the PT method, a first run for sampling the parameter
space was executed with 64 different temperatures. After this
initial sampling, a second run with very low temperature (all nodes
the same temperature) was executed in order to reach the local
minima for each parallel replica. The starting points were the
parameters corresponding to the minimum cost function value
attained in the previous runs.
Figure 2 shows the histograms of the minima of the cost
function attained by each of the methods investigated. We observe
that many of the minima found by the Simplex Method are orders
of magnitude larger than those found by the other methods, with
the smallest minimum of the cost function being in the 100’s (in
the non-dimensionalized units of length squared). In some runs
MIGRAD execution had to be interrupted before finishing
because it reached the stipulated maximum number of iterations;
in these cases, we called ‘‘minima’’ the smallest values calculated
up to that point. MIGRAD and PT were able to find similarly
good values, with the smallest minima of the cost function being
around 20. The LM method clearly found the best minima of the
cost function, with smallest values being around 2 (Figure S2 in
File S1).
To further study the differences between the LM and PT/
MIGRAD minima, we applied Principal Component Analysis
[35] (PCA) to the LM solutions. The direction that explains most
of the variance has mainly components on the 4th and 6th
parameters. Applying PCA to the solutions reached by the others
methods with good parameter space sampling (Migrad, PT)
yielded two main principal components for which, as was the case
for LM, parameters 4th and 6th have the largest components.
Thus we plot the projection of the minima sampled by the
different methods on the plane given by the 6th (cbd) and the 4th
(cc) parameters. This two-dimensional glimpse of the six-
dimensional parameter space is shown in Figure 3 for all the
methods considered.
The Simplex method (top right subfigure) shows a very poor
parameter space coverage and a rather high range of cost function
values at the attained minima as evidenced by the scale of the
color bars to the right of the figure. MIGRAD and PT show a
similar tendency toward finding minima in the high range of the
6th parameter values. LM shows the best set of minima with a very
significant lower value for the 6th parameter, in contrast with the
tendencies in the MIGRAD and PT runs. It is also interesting to
highlight the very different search strategies of the different
methods. By construction, PT implements a stochastic search
strategy, and therefore reaches corners of the parameter space not
sampled by the other methods. LM has a good coverage of the
parameter space, and it takes a more ordered but yet rather non-
local search of the phase space. MIGRAD performs a localized
search, more local than PT and LM, but less local than Simplex.
In the latter, the original starting mesh of the simulations can be
clearly identified, and not too far reaching excursions from the
original mesh are explored.
The location and number of local minima shown in Figure 3
suggest that the cost function landscape is a rather rugged one,
plagued with local minima. In Figure 4 we explicitly constructed
the surface of the cost function as a function of parameters 4 and 6,
using all the runs available from all the optimization methods used,
yielding a total of more than 100,000 evaluations. This figure
shows an extremely rugged landscape with many peaks and valleys
permeating the parameter space. This ruggedness is smoothed out
by the fact that the value of the cost function shown in Figure 4 is
the average over of the cost function values with the same values of
parameters cbd and cc, but different values for the other four
Figure 2. Histograms of the minima of the cost function obtained using different optimization methods. In all cases, runs started from a
fixed 6-dimensional mesh of 64 points, in which each parameter was evaluated at 2 values. The optimization methods were launched and run until
convergence, and the minimum obtained in each run was recorded to create these histograms.
doi:10.1371/journal.pone.0013283.g002
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function landscape, such as plotting the minimum over of the cost
function with the same values of parameters cbd and cc. This
alternative representation of the cost function yielded a similarly
rugged landscape (data not shown).
Can the ruggedness of the cost function landscape be due to the
noisy nature of the data being fitted? It could be conjectured that
noiseless data would yield a cost function landscape that is less
plagued with local minima. If this were the case, it would make
sense to smooth out the data before fitting a model to it. To
address this question we recalculated the landscape removing the
5% noise that had been added to the Gompertz curve, and
therefore fitting the model to a smooth curve. The results (data not
shown) show a landscape with a similar ruggedness as that of
Figure 4, indicating that the rough surface cannot be attributed to
the noise in fitted data.
To explore the behavior of the parameter space over the other
parameters, we show the sampled parameter space projected onto
the 5th (cd) and the 1st (d) parameters in Figure 5 for LM, PT and
MIGRAD, the three methods with good minima sampling.
Minima found with LM resulted in 5th parameter values very
close to zero. Even though MIGRAD and PT show a similar
tendency, the minima values reached by these methods are not as
low as those obtained by LM. One way to explain this difference is
that PT bases its searches on random moves, and the probability of
getting in a trough as narrow as 10{8 (the value found by LM for
parameter 5) is very unlikely. On the other hand, as we said
before, MIGRAD was interrupted before finishing because the
number of iterations performed reached the maximum stipulated.
As the MIGRAD method resembles LM, it might be expected that
a sufficiently long MIGRAD run would eventually reach similar
minima values as LM, albeit in many more iterations.
Even though many of the 64 minima obtained in each method
had similar values of the cost function (Figure S2 in File S1), the
corresponding parameter values were not necessarily close. In
order to understand the structure of the parameter sets found
Figure 3. 6th (cbd) vs. 4th (cc) parameters runs for all methods. Grey points represent individual runs. Colored points are the best cost function
values obtained in for each of the 64 initial conditions. The value of the attained minimum for each run is color-coded in the color scale at the right of
each subfigure. Note that the color bars have different scales.
doi:10.1371/journal.pone.0013283.g003
Figure 4. The landscape of the cost function as a function of the 6th (cbd) and 4th (cc) parameters. The cost function value has been
averaged over the values that correspond to the same values of cbd and cc, but for which the other coordinates differed. This data was taken from all
runs available of all methods.
doi:10.1371/journal.pone.0013283.g004
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standard hierarchical clustering techniques (Figure S3 in File S1).
As a metric for the hierarchical clustering we used the correlation
between the parameter vectors (normalized inner product), and
used average linkage as the method for hierarchical agglomeration
of clusters.
We divided the sets of minima into seven clusters for each
method. The clusters resulting from the LM optimization are
tighter and more homogeneous within clusters than those resulting
from PT. For each of the seven clusters and each method the
mean value of each parameter was chosen as the representative
solution (Table S1 and Table S2 in File S1).
Conventional wisdom would indicate that the best parameter
set is the one that minimizes the cost function, i.e. the best fit to the
experimental data. In the present case, the parameter set that
yielded the minimum from LM method would have been chosen.
Notwithstanding, growth curves from all minima closely followed
the experimental growth curve (see Figure S2 in File S1). Even
though we have 100 points to constrain the six parameters of the
model, there is still the possibility that the optimization has
‘‘forced’’ the parameters of model to data. We claim that
optimality of the cost function is not the only criterion for
choosing the best parameters: the best parameters have to be
interpretable, and should compare well with their experimentally
measured counterparts. The current literature provides very good
experimental measurements for b and cc (the 3rd and 4th
parameters, respectively). Therefore we checked the consistency of
the parameters obtained from our optimization of the cost
function with the experimentally measured values of b and cc.
In Figure 6 we plot the minima obtained by the different
optimization methods (solid points) and the cluster centroids (x
symbols). In the figure blue and green correspond to LM and PT
methods respectively. The biological realistic values reported in
literature are shown in the gray box.
Only one minimum centroid for each method was within the
biologically feasible values. Surprisingly, neither of these two
parameter sets corresponded with the cluster that contained the
minimum for either PT or LM. This is a counterintuitive result, as
one would expect that the global minimum is the one that
optimizes all aspects of the solution. However, the results shown in
Figure 6 clearly show that only a few of the minima are
biologically realistic, and the global minimum is not amongst
these. We shall discuss this issue further in the Discussion section.
Both parameters sets that yield values consistent with the known
biology are very similar, except for the 5th parameter which in LM
is seven orders of magnitude smaller than in the PT minima. In
order to shed some light into this difference we performed
sloppiness analysis [7,8] for the model around the parameter sets
given by the two centroids. In sloppiness analysis, a slightly
modified cost function is used, in which the values datak are
replaced by the values of the model at the optimal parameter
yk(h
 ). The Hessian of this modified cost function is computed,
and its eigenvalues and eigenvectors are studied. The spectra of
eigenvalues for our system had a very wide range of values, with
the ratio of the maximum to the minimum eigenvalues being
separated by several order of magnitude. The eigendirections
corresponding to the large eigenvalues are stiff directions, whereas
the sloppy directions in parameter space are those directions in
which an excursion doesn’t change the modified cost function
considerable. Generally, the directions determined by the
eigenvectors in sloppiness analysis are linear combination of
parameters. In both methods (LM and PT) the minimum
eigenvalue corresponded to an eigenvector which was essentially
the vector (0,0,0,0,1,0). Therefore, the difference of several orders
of magnitude difference in the 5th parameter may be explained by
the fact that this parameter corresponds to the most sloppy
direction in parameter space, at least in the neighborhood of the
centroids.
Discussion
When the optimal is not the best
The avascular tumor model used in this work has 6 parameters,
each of which represents a physiological mechanism. We fitted
these six parameters to data derived from a three-parameter
Gompertz curve with added error. Is there any point in trying to
fit data that can be fitted with three parameters to a much more
complicated model with six parameters? We believe that this
parameter-counting argument (six parameters in a model to fit a
three parameter Gompertz curve) can be misleading. The
avascular tumor growth presented here is a nonlinear partial
differential equation in which the solution rbd(t) depends subtly on
the equation parameters. If the full model were perfect (to within
the error), the optimization should find physiologically reasonable
parameters that reproduce the data in an indistinguishable way
from the Gompertz curve, regardless of the fact that the data can
also be fitted with an empirical model of 3 parameters plus noise.
One of the main conclusions of this paper is that the notion that
model parameters have to be obtained by global minimization of a cost function
may be too strong a generalization. Parameter fitting requires not just
brute-force computation but also some strategic thinking. The
problem is not so much fitting the data at hand, but rather the
Figure 5. All optimization runs as seen from the cut of the parameter space through the 5th (cd) and 1st (d) parameters, for the LM,
PT and MIGRAD methods. Gray points represent individual runs. Color points are the best cost function value obtained in each compute node.
The color bars coding the value of the cost function at the minima are in different scales for the different methods.
doi:10.1371/journal.pone.0013283.g005
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from the ones used in the fitting. This is a similar problem as the
one faced in machine learning when we want to generalize a
classifier to previously unseen data after training it in a training set:
a perfect fit to a training set may be due to overfitting, and may
result in poor generalization to previously unseen data. In terms of
mechanistic models, a perfect fit may result from the fact that the
data to be fitted is in the realm of possible outcomes of the model,
even with unrealistic parameters. In this section we will elaborate
further on these ideas.
In the problem studied in this paper, we formulated the model
of avascular tumor growth based on a set of parameters with a
relatively clear interpretation. At least some of these parameters
could in principle be contrasted to experimentally measured
parameters. In this framework, we have presented a methodolog-
ical approach for parameter estimation and evaluation of an in-
silico model of avascular tumor growth. We evaluated several
algorithms to find best-fit parameters, and encountered a
proliferation of local minima embedded in a very rough cost
function surface. We clearly found a best performing optimization
method in LM, which efficiently sampled the parameter space and
found what appears to be the global minimum of our cost
function.
The optimal parameters obtained by our extensive search of the
parameter space was not, however, the best minimum in the sense
of making the model interpretable. Indeed, the global minimum
consisted of values for the parameters cc and b that were outside of
the region where experiments place these parameters. Therefore,
even if the fit to the growth curve of the model with the global
minimum parameters optimized the cost function, any additional
measurement that depends crucially on the value of these
parameters would make the model fail to match the data. In
other words, in our case, the optimal minimum of the cost function
was not the best solution of our problem as it yielded an unfeasible
parameter set. The two sets of (cluster centroid) parameters which
were consistent with the literature showed a reasonable fit, albeit
not optimal. Indeed, the relative error of the model at those
parameter values fall outside the error bars of the experimental
data (Figure S4 in File S1).
This seemingly paradoxical situation in which the optimal
parameter set may not be the best solution to our problem can be
illustrated with a simple example. Suppose that we have a set of
measurements that depend on a non-dimensionalized time t
according to data(t)~tzt3. Suppose that our model is of the
form y(t)~atzbt2. It is clear that our model, while qualitatively
correct, is not exact. Continuing with our example, assume that we
have collected data from time t~0 to time t~T (where T is also
non-dimensional). The cost function that we need to minimize is:
x2(a,b;T)~
Ð T
0 dt½y(t){data(t) 
2
~
Ð T
0 dt½(a{1)tzbt2{t3 
2:
The global minimum of this function is obtained at parameter
values a  and b
  given by the relations:
a ~1{
2
5
T2, b
 ~
4
3
T:
The best value for the parameter a should be 1, as this
parameter represents the importance of the linear coefficient of the
data whose linear coefficient is 1. Indeed a  is close to 1 for small
values of T, which is where the model best represents the data.
However, if we sampled for a longer time, the paradoxical
situation results that our estimate of the parameters worsens. It is
clear that the parameter b while trying to capture the curvature of
the data, is parameterizing the wrong dependence (a t2
dependence rather than the t3 dependence of the data in our
example). For a long sampling time T, the parameter b grows
Figure 6. cc vs b points of all minima found (dots) and cluster centroids (crosses). Blue and green represents the minima obtained using the
LM and PT methods respectively. The gray box shows the biologically feasible parameter space.
doi:10.1371/journal.pone.0013283.g006
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the model in order to fit the data. The parameter a also has to
compensate in order for the model to match the data at the high
range of t. So, if T~0:5, the values of a  and b
  are 0:9 and 0:67,
very close to the actual values of 1 and 1 respectively. However, if
T~5, we would have a ~{9 and b
 ~6:67: clearly the linear
term is assuming negative values, very far from the reality of the
actual data. The optimization process has forced the parameters to
fit the data and in so doing, the parameters lost their
interpretability of being the linear coefficient and a coefficient
related to curvature.
Our intention in presenting this analytical example is to show
that when the data is not in the realm of the results that the model
can produce, the optimal of the cost function may not yield a
meaningful set of parameters. Our simple example makes this
point obvious, as we know the functional form that represents the
data.
There is another lesson that we can extract from this simple
example. It is clear that the optimal parameter values depend on
the range of the data to be fitted. Therefore, one simple test of the
sanity of a model’s optimal parameters is to fit the data at different
time points (or in data sets with different range of values). If the
optimal parameters dramatically depend on the range of the data
to be fitted (such as the dependence of a  and b
  on T), then
something is wrong with the model.
In their interesting discussion on modeling in systems biology,
Cedersund and Roll [36] suggest that a model can be viewed
under three epistemological lenses: 1) A model is used as an
instrument (as a means) to obtain a certain prediction (instrumen-
talism). Typically this is the approach that is used when data is
modeled using generic statistical methods such as regression; 2) A
model is to be the ‘‘perfect’’ representation of the real system
(direct realism), as is the quest when theoretical physicists seek the
ultimate laws of nature. This means that the ‘‘perfect’’ model will
not only be able to give accurate predictions of the measurable
system output, but also will provide an accurate description of all
the components and processes involved in the generation of this
output. 3) An intermediate view exists between 1) and 2) according
to which a model yielding good predictions on a diverse data set
could be expected to contain some degree of correlation between
its mechanisms and the corresponding mechanisms of the real
system (critical realism). In this view, a model is considered as a
simplification of the true system that only captures some of its
aspects, and one therefore has to be careful when drawing
conclusions about what these aspects might be. For the avascular
tumor model discussed in this paper, some of the simplifications
were the assumed perfect spherical symmetry, the Michaelis-
Menten growing behavior, the disregard for the discrete nature of
the cellular composition of the tumor and the mechanical stresses
that cells exert on each other, etc. Cedersund and Roll suggest,
and we agree, that of these three approaches (i.e. instrumentalism,
direct realism and critical realism), it is the last option that best
describes modeling for systems biology. When our models are
simplified version of reality and therefore not exact, the best
parameters (in the sense of being physiologically meaningful) may
not be found by optimization.
If parameter estimation cannot simply rely on cost function
optimization, how are we to choose our parameters to determine
our models? We believe that the optimization of a cost function,
even a cost function with regularization, is only one side of the coin
in the fitting process, and that experimental design [37] has to be
considered simultaneously with the optimization process. If we
have independent data sets probing different regimes of a system, a
good strategy may be to take all the local minima solutions that fit
the first data set to within an approximation (but not just the global
minimum, assuming it can be found), try each of those solutions on
the new dataset, and choose the parameter set that fits the best to
the second data set. Some experiments will determine some
parameters better than others, so a reasonable strategy for
parameter fitting is to produce independent experiments that
constrain different parameters. Lumping all the experiments in a
single cost function may not be the best approach to find
parameters from data, as parameters values may be strained until
the data at hand is fitted. It may be preferable to fit the model with
a subset of experimental data, and contrast the resulting minima
with the rest of the experimental data, specially reserved for this
purpose. This approach is akin to the cross-validation technique
used in statistical learning.
A formalization
To further explore how the approach sketched in the previous
paragraph can be applied, we next describe a formal methodology
to choose model parameters in the avascular tumor growth model
or any other biological system. We start by sampling the cost
function x2(h,D1) with a first constraining data set D1. In the case
of the avascular tumor growth model D1 was the spheroid radius-
versus-time data. Rather than just choosing the parameter h
 
1 that
minimizes the cost function as the ‘‘true’’ parameter values, we
postulate that the ‘‘best’’ parameter values are contained in the set
S1(e) of parameters that render the cost function not larger than
e2. The choice of e will depend of the experimental error s in the
data, and on the error eM in the fit due to simplifications of the
model, plausibly following the relation e2~s2ze2
M. S1(e) is thus
defined as
S1(e)~ hDx2(h
 
1,D1)ƒx2(h,D1)ƒe2   
It may be expected that a simplified model at its best parameters
(i.e., realistic and amenable to predict the results of new
experiments) can represent the data, albeit with a relatively large
eM. If the model is based on first principles, one could expect eM to
be very small, as the theory should account for the data very
faithfully. A principled value of eM (and thus of e) is hard to
determine, but an empirical way for its computation will be
discussed below.
The next step in the process is to choose a subset of the
parameters contained in S1(e) that are consistent with other data
sets. In the case of our avascular tumor growth model, possible
additional data sets can be extracted from the following
experiments: 1) changing the nutrient concentration of the
surrounding medium of the spheroid to obtain different saturation
levels of growth curves and 2) measuring the necrotic core size, for
example by histological or immunohistochemical markers. These
experiments will generate additional data sets D2,D3,..., etc. In
general, the nature and design of these additional experiments will
depend on the system being studied. The n-th experimental data
set Dn will determine the n-th plausible parameter set Sn(e)
defined as
Sn(e)~ h=x2(h
 
n,Dn)ƒx2(h,Dn)ƒe2   
where h
 
n is the parameter that minimizes x2(h,Dn). If we want the
e to be the same for all plausible parameter sets, the cost functions
have to be normalized by the number of experimental data points.
If we have a total of k datasets, we want to find those parameters
that satisfy the constraints imposed by all datasets. This is simply
When Optimal Is Not the Best
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data set:
S(e)~
\ k
i~1
Si(e)
We choose e to be the minimum such that S(e) is non-empty.
If S(e) has only one element, we take that to be the best
parameter. If it has more than one parameter, we take the best
parameter value as the one that minimizes the cost function
x2(h,D1,D2,...) constructed using all the available data sets. If the
value of the resulting e is too large, then the fits of the model
through the data sets are very poor, indicating that the model is
too rough to represent the data, and needs to be refined. If the
model can produce an acceptable e, with reasonable fits through
the data, then the model is a good representation of the actual
system in the realm of the mechanisms probed by the experiments
that produced the datasets D1,D2,...,Dk.
It is interesting to make a parallel between cost function
optimization and thermodynamics. In a thermodynamic system at
zero temperature, we expect the system to be found in a microstate
that minimizes the internal energy. If we increase the temperature,
the system will be able to attain other energy states, and at some of
these energies there may be a large number of compatible
microstates. At a given finite temperature, the system will not be
typically found at the microstate that attains the minimum energy,
but at a set of microstates that negotiate a balance between having
as small an internal energy as possible, and as many microstates
available as possible (i.e., as large an entropy as possible). The
internal energy at a finite temperature is no longer the global
minimum of the internal energy. Rather, the internal energy
adjusts itself to be at a value in which the system minimizes its free
energy. The parallel with our parameter estimation problem is as
follows. The space of model parameters is equivalent to the set of
microstates in a thermodynamics system. When e is zero (zero
temperature), i.e., there is no experimental noise, and the model is
a perfect representation of reality, we expect the actual parameters
of the model to be those that minimize of the cost function (as the
microstate of the thermodynamics system at zero temperature
corresponds to the minimum of the internal energy). However,
when e is non-zero, many parameter values are compatible with
the same value of the cost function, and we cannot any longer
claim that the right parameter set is the one that minimizes the
cost function (as we cannot say that at finite temperature the right
microstate of the thermodynamic system is the one minimizes the
internal energy). In the case of the parameter estimation problem,
it may be possible to define a modified cost function that is the
equivalent of the free energy in the thermodynamic system, and
which is minimized at the set of parameters compatible with a
given e. This discussion, however, is beyond the scope of the
present paper.
Final conclusions
We conclude that, in the absence of a model based on first
principles, parameter estimation cannot just rely on cost function
optimization. We have seen that it is necessary to double-check the
parameters to identify possible runaway solutions given the
complexity of the solution space. Our independent assessment of
the parameters with data not used for cost function optimization
allowed us to further restrict the minima and reach a compromise
between cost function optimality and biological plausibility. We
submit that this approach should be considered as an important
part of the process of assigning parameters to complex biological
models.
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